CRBN and neoplasm: Intriguingly, a greater reduction in tumor xenograft burden was observed when combining PROTAC 008 treatment with FER knockdown, possibly due to the off-target degradative activity of PROTAC 008 on other kinases such as AAK1 and GAK or the PROTAC-mediated inhibition of cereblon.